CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-11 | Kwon Paul Chief Scientific Officer | Exercise or conversion | +80,300 | 80,300 | ||
| 2019-12-11 | Kwon Paul Chief Scientific Officer | Shares withheld for taxes | −27,766 | $4.52 | $126K | 52,534 |
| 2019-12-11 | Kwon Paul Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −80,300 | 0 | ||
| 2019-12-11 | Kwon Paul Chief Scientific Officer | Exercise or conversion | +80,300 | 80,300 | ||
| 2019-12-11 | Kwon Paul Chief Scientific Officer | Shares withheld for taxes | −27,766 | $4.52 | $126K | 52,534 |
| 2019-07-29 | Kwon Paul Chief Scientific Officer | Grant or award · Restricted Stock Units | +80,300 | 396,812 | ||
| 2019-07-29 | Kwon Paul | Grant or award · Restricted Stock Units | +80,300 | 396,812 | ||
| 2018-12-10 | Kwon Paul Chief Scientific Officer | Grant or award · Stock Option | +64,000 | 64,000 | ||
| 2018-05-03 | Kwon Paul Chief Medical Officer | Grant or award · Stock Option | +64,000 | 252,512 |
Page 1 of 1 · 9 trades